Seoul, South Korea

Myung Hwan Kim

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 7.2

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Yangsan-si, KR (2016)
  • Seoul, KR (2018 - 2023)

Company Filing History:


Years Active: 2016-2023

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: Myung Hwan Kim: Innovator in Pharmaceutical Composition

Introduction

Myung Hwan Kim is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at treating serious health conditions. With a total of five patents to his name, Kim's work reflects a commitment to innovation and improving patient outcomes.

Latest Patents

Among his latest patents is a novel benzylideneacetone derivative, which is designed for use in pharmaceutical compositions aimed at preventing or treating cancer and bone diseases. This invention focuses on a compound defined by a specific formula, which serves as an active ingredient in these compositions. Another significant patent involves a composition containing a monoacetyldiacylglycerol compound, which is effective in inhibiting blood cancer and metastasis. This compound has shown promising results in reducing the expression of IL-4 and inhibiting the activity of STAT-6, thus overcoming the side effects associated with current treatments.

Career Highlights

Myung Hwan Kim has worked with prominent organizations such as Enzychem Lifesciences Corporation and the Korea Research Institute of Bioscience and Biotechnology. His experience in these institutions has allowed him to collaborate on various innovative projects that aim to advance medical science.

Collaborations

Some of his notable coworkers include Jae Wha Kim and Kyung Seop Ahn. Their collaborative efforts have contributed to the success of the projects they have undertaken together.

Conclusion

Myung Hwan Kim's contributions to pharmaceutical innovation are noteworthy, particularly in the development of compositions for treating cancer and blood diseases. His work continues to impact the field positively, showcasing the importance of research and innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…